Leaderboard

Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie 03. Mai 2026
Suchen
Gastroplattform
Neoplasie
Erweiterte Suche
Abklärungen / Diagnostik
Therapien
Guidelines
Fortbildung
News / Journalscreening
Fachliteratursuche
Gallenwege
Leber
Magen-Darm
Oesophagus
Pankreas
Neoplasie
Pankreatitis
Anderes
Kongresse / Tagungen
Services / Tools
Links
Rect Top
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 2995  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 59897  
   
Association between bedroom nighttime light pollution and risk of hepatic encephalopathy in hepatocellular carcinoma patients: a prospective cohort study.
Sci Rep
Li S, Zhang S, Li S, Meng T, Feng H.
PMID: 42069906 [PubMed - as supplied by publisher]


Machine learning-enhanced plasma proteomics discriminates pancreatic cancer-associated diabetes from type 2 diabetes mellitus.
J Proteomics
Lazari LC, Donnarumma CDC, Matheus LHG, D'Alpino Peixoto R, de Matos MR, Valerio HP, Rosa-Fernandes L, Oba-Shinjo SM, Machado MCC, Machado MAC, Marie SKN, Correa-Giannella ML, Palmisano G.
PMID: 42069247 [PubMed - as supplied by publisher]


Artificial intelligence-driven early screening and diagnosis of pancreatic cancer: technical innovations, clinical applications, and precision medicine strategies.
J Adv Res
Li YR, Li D, Zhou YW, Wang WE, Ma YS, Liu XY, Yang QX, Lu CN, Cai YF, Yang C, Chu KJ, Dong H, Yu H, Fu D, Wu WG, Zhang Y, Xue P.
PMID: 42069141 [PubMed - as supplied by publisher]


Molecular dissection of pancreatic cancer signaling: Toward targeted therapies for KRAS, MDM2-TP53, EGFR, and PI3K/AKT/mTOR.
Pathol Res Pract
Singh NK, Ahmad F, Husain A.
PMID: 42068765 [PubMed - as supplied by publisher]


Predicting Prognosis for Gastric Cancer Patients Receiving Neoadjuvant Treatment With Body Composition-Based Deep Learning.
Cancer Med
Zhang Y, Tong T, Hou B, Yu T, Su P, Yu J, Huang Y.
PMID: 42068095 [PubMed - indexed for MEDLINE]


Progress and challenges in the development of advanced pancreatic cancer organoids.
J Exp Clin Cancer Res
Detert K, Piotrowsky A, Marongiu L, Leischner C, Lauer UM, Venturelli S, Burkard M.
PMID: 42067869 [PubMed - as supplied by publisher]


Differentiating walled-off pancreatic necrosis with no documented pancreatitis from mucinous cystic neoplasms: a multicenter LASSO-based nomogram.
BMC Gastroenterol
Xu J, Huang X, Duan J, Chen X, Zheng X, Wang Y, Fan S, Wang W, Yu R.
PMID: 42067811 [PubMed - as supplied by publisher]


Apilimod in Oncology: From Non-Malignant Origins to Emerging Anti-Cancer Potential.
Eur J Pharmacol
Evrard C, Gündel B, Löhr M, Heffinger L, Heuchel R.
PMID: 42067017 [PubMed - as supplied by publisher]


Rare pathological types of gallbladder cancer: Cases report.
Medicine (Baltimore)
Wang H, Wang Z, Zhao Y, Xiang Y, Li J, Tuo H.
PMID: 42065192 [PubMed - indexed for MEDLINE]


Current Advances in Preclinical Patient-Derived Cultivation Models for Individualized Drug Response Prediction in Pancreatic Cancer.
Oncol Res
Heckelmann B, Duhn J, Braun R.
PMID: 42065069 [PubMed - indexed for MEDLINE]


Cancer-Associated Arterial Thrombosis: Mechanisms and Risk Factors.
Oncol Res
Lalechou K, Pantazi D.
PMID: 42065044 [PubMed - indexed for MEDLINE]


Type 2 diabetes mellitus and cancer: A systematic review and meta-analysis of Mendelian randomization studies.
Front Endocrinol (Lausanne)
Wu W, Huang GL, Cui J.
PMID: 42064762 [PubMed - indexed for MEDLINE]


Drug resistance mechanisms of immunotherapy and translational strategies for reversing resistance for hepatocellular carcinoma: from bench to bedside.
Front Immunol
Zhang C, Zhang D, Wen X, Liu S.
PMID: 42064051 [PubMed - indexed for MEDLINE]


Estimating the impact of scaling up workforce personnel on global cancer mortality from 2030 to 2050: a simulation-based analysis of 17 cancers and 18 personnel types.
Lancet Oncol
Ward ZJ, Moraes FY, Scott AM, Favorito FM, Ngwa W, Rebbeck TR, Gopal S, Dako F, Avery S, Loehrer PJ, Hricak H.
PMID: 42061369 [PubMed - indexed for MEDLINE]


Estimating total and diagnosed global cancer incidence and stage distribution from 1990 to 2050: a simulation-based analysis of 17 cancers.
Lancet Oncol
Ward ZJ, Moraes FY, Scott AM, Rebbeck TR, Loehrer PJ, Hricak H.
PMID: 42061367 [PubMed - indexed for MEDLINE]


Growth hormone receptor blockade in cancer treatment.
Growth Horm IGF Res
Guevara A, Kopchick J.
PMID: 42061055 [PubMed - as supplied by publisher]


Clinical use of Ankaferd Blood Stopper in wound healing: a case study of a patient with burns and pancreatic cancer.
J Wound Care
Díaz PP.
PMID: 42060509 [PubMed - indexed for MEDLINE]


Long-Term Outcomes of Patients With BRCA+ or PALB2+ Pancreatic Cancer Treated With Maintenance Rucaparib: A Secondary Analysis of a Nonrandomized Clinical Trial.
JAMA Oncol
Reiss KA, Xia M, Akamandisa M, D'Andrea K, Wubbenhorst B, Lord CJ, Pettitt SJ, Tutt ANJ, Brown TJ, O'Hara MH, Schneider C, Teitelbaum U, Hannan Z, Hood R, Tondon R, Vonderheide RH, Domchek SM, Nathanson KL.
PMID: 42060271 [PubMed - as supplied by publisher]


MET Amplification in Gallbladder Cancer: a Case Report on a Precision Medicine Approach with Glumetinib and Envafolimab.
J Gastrointest Cancer
Wu XJ, Nie X, Xu JF, Gui RJ, Duan HX.
PMID: 42060015 [PubMed - in process]


Mistletoe extract in patients with advanced pancreatic cancer: Health-related quality of life in a double-blind, randomized, placebo-controlled trial (MISTRAL).
Palliat Med
Wode K, Björ O, Klein R, Elander NO, Fransson P, Henriksson R, Sharp L, Scheibling U, Johansson B, Hök Nordberg J, Kienle GS.
PMID: 42059487 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 59897    Seite 1 von 2995  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Ironmedline

Das Fachportal für Eisenmangel >>

 

Sky right 1